Locations
England, UK · United Kingdom · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2019
Aviado Bio is dedicated to developing transformative gene therapies for neurodegenerative disorders such as frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Leveraging pioneering research from King’s College London and the UK Dementia Research Institute, the company focuses on precision delivery and innovative gene therapy platforms to maximize therapeutic potential. Their unique approach aims to address the unmet medical needs of patients suffering from these debilitating conditions, with ongoing clinical trials and partnerships to advance their promising therapies.
Something looks off?On-site & Remote